NAUT vs NDAQ · $103.4M cap vs P/E 41, rev $2.53B
Nautilus Biotechnology Inc (NAUT) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
Nautilus Biotechnology Inc (NAUT) is a biotechnology company listed on US.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
NAUT does not have a complete income-statement cache yet.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
NAUT currently screens at market cap $103.4M. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the NAUT and NDAQ stock pages for the full models.
Not investment advice.